Search research articles
Contact Us
Filters
Showing results (101-110 of 104) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 104 results.
Oncology and Therapy
|
October 2, 2025
Abemaciclib Persistence in Patients with HR+, HER2-, Node-Positive Early Breast Cancer: a Real-World Analysis
Kathryn Hudson, Wambui Gathirua-Mwangi, Lindsay A Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2008
Nitrogen fixation island and rhizosphere competence traits in the genome of root-associated Pseudomonas stutzeri A1501
Yongliang Yan, Jian Yang, Yuetan Dou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2017
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study
Ian Chau, Markus Peck-Radosavljevic, Christophe Borg, et al.
Clinical and Translational Medicine
|
January 19, 2021
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer
Wei Wang, Yu Zhong, Zhenkun Zhuang, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 104) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 104 results.
Oncology and Therapy
|
October 2, 2025
Abemaciclib Persistence in Patients with HR+, HER2-, Node-Positive Early Breast Cancer: a Real-World Analysis
Kathryn Hudson, Wambui Gathirua-Mwangi, Lindsay A Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2008
Nitrogen fixation island and rhizosphere competence traits in the genome of root-associated Pseudomonas stutzeri A1501
Yongliang Yan, Jian Yang, Yuetan Dou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 8, 2017
Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib: Patient-focused outcome results from the randomised phase III REACH study
Ian Chau, Markus Peck-Radosavljevic, Christophe Borg, et al.
Clinical and Translational Medicine
|
January 19, 2021
Multiregion single-cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancer
Wei Wang, Yu Zhong, Zhenkun Zhuang, et al.
Page
of 11